In a new job - August 5, 2022
Calliditas announces additions to the management team
Calliditas Therapeutics has added two members to its management team, Head of Human Resources Sandra Frithiof and Group General Counsel Jonathan Schur. Jonathan Schur has over 40 years of experience as a lawyer, is a member of the New York Bar, and is a former member of the Paris Bar. In private practice he worked […]
In a new job - August 4, 2022
Valo Therapeutics announces Scientific Advisory Board
Valo Therapeutics has announced four appointments to its Scientific Advisory Board (SAB), Professor Paolo A. Ascierto, Dr Jeffery Bockman, Professor Malcolm K. Brenner, and Professor Kevin Harrington. “We are delighted to welcome our distinguished, and expert, new SAB members. They bring a wealth of scientific and clinical understanding which will be of great help in […]
In a new job - August 1, 2022
Nykode Therapeutics appoints Chief Development Officer
The company has announced the appointment of Klaus Edvardsen as Chief Development Officer. “I am very pleased to welcome Klaus to Nykode Therapeutics’ executive management team. Klaus brings tremendous international leadership experience in directing successful drug development programs at renowned biopharmaceutical companies. As Nykode’s candidates continue to advance through the clinical, we are eager for […]
In a new job - July 1, 2022
Bio-Me appoints International Sales and BD Manager
Bio-Me has employed Dr. Anne-Grethe Reichelt as International Sales and BD Manager. This step is part of the company’s plan to widen commercial adoption of their existing product portfolio as well as launching new products under development, it states. Anne-Grethe will report to Chief Business Officer Runar Vige. “This is a milestone hire for Bio-Me: […]
In a new job - June 9, 2022
BioInvent appoints Chief Business Officer
BioInvent International has announced the appointment of Sylvie Ryckebusch as Chief Business Officer (CBO). “Sylvie Ryckebusch has already made an important contribution to the development of BioInvent’s business, including the licensing deal with CASI Pharmaceuticals in 2020, the restructuring of a clinical development agreement with Cancer Research UK in 2021, and a supply and clinical […]
In a new job - June 7, 2022
Qlucore appoints Head of Diagnostics sales
Qlucore employs Erik Söderbäck as head of diagnostics sales. Erik Söderbäck has over 30 years of experience in DNA sequencing and most recently came from QIAGEN Europe, where he was responsible for market development of products and solutions for clinical genomics. He joined the team April 7th. “Through Eriks Söderbäck’s expertise and extensive experience in […]
